What Axactor Bears Spotted Before The Slide

Axactor looked like a classic disagreement story at the start of 2026. Bulls pointed to new NPL investments, digital collection tools and fresh 3PC contracts. Bears focused on regulation, leverage and a shrinking addressable market. Holding Axactor from the start of the year would have meant a 42.4% loss, including dividends. If you were weighing those opposing views back then, what clues were already on record before the later collapse in revenue and profit?

The easy part of this move is behind Axactor. Zero in on 198 high quality undervalued stocks for companies trading below our estimates.

The Two Axactor Stories Investors Had To Weigh

The shares cost NOK7.78 at the start of the period, and investors in Axactor were choosing between two very different but plausible stories.

On the optimistic side, one camp saw a Fair Value of NOK10.03, a price implied by upbeat assumptions, based on heavy investment in new NPL portfolios and digital collection platforms, plus an assumed 32.6% annual revenue growth rate over three years.

The more cautious view put Fair Value at NOK6.8 and focused on tightening European regulation that could shrink the NPL pool and raise compliance costs for Axactor, alongside concern over high leverage and refinancing risk.

What The Axactor Results Put To The Test

The sharp swing in Axactor’s numbers gave investors a stark reality check. Reported revenue moved from €63.229m in Q2 2025 to a revenue decline of €258.249m in Q2 2026, while a €6.894m profit turned into a €314.521m loss. That scale of setback leaned toward the cautious case that focused on leverage, regulation and earnings fragility.

The lesson to apply elsewhere is simple: when a bullish story leans on improving profitability, keep testing that claim against reported net income and any large revenue swings rather than only watching growth forecasts.

What Axactor’s Drop Now Asks You To Believe

Axactor trades at NOK4.18, and the selected Narrative’s Fair Value sits above that level based on its own framework rather than a settled truth. The argument leans on recurring collections income, tighter cost control and a cleaner balance sheet offsetting pressure on the non performing loan pool.

For the recent fall to be an opening instead of a warning, a buyer today would need to believe Axactor can turn sector consolidation, digital tools and extended funding lines into steadier margins despite regulation and a shrinking NPL supply.

"Sustained double-digit growth and margin expansion in the capital-light 3PC segment, combined with clear evidence of winning market share in core geographies such as Norway and Spain, positions Axactor for recurring fee income growth and operating leverage, supporting both future revenue and net margins."

One Narrative disagrees with today's price. → See where this Narrative says Axactor should trade

Before The Next Story Makes Headlines

This company's disappointment is already part of the story. Your next idea could come from looking where the price and the possibilities still seem far apart. Here are three companies priced below our estimates.

• Company 1 - 33% below our estimate - targets demand for packaged nutrition by widening product range and export reach.
• Company 2 - 45% below our estimate - builds a lifestyle label by adding flagship stores and omnichannel retail in new hubs.
• Company 3 - 29% below our estimate - pushes probiotic supplements into mainstream chains as adult health awareness increases.

Those are three of them. See every one of the 201 solid balance sheet companies →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com